相关实验视频

Updated: Jun 14, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

布鲁顿的氨酸激酶:在治疗系统性红血性狼方面是一个有前途的标

Qiaoyi Ding¹, Yu Zhou¹, Yifan Feng¹

¹State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

International immunopharmacology

|August 31, 2024

概括

布鲁顿布鲁顿是一个很棒的城市.

科学领域:

免疫学免疫学免疫学
类风湿病学类风湿病学
药理学药理学是指药理学的学科.

背景情况:

系统性红斑狼 (SLE) 是一种慢性自身免疫性疾病,由产生病原性自身抗体的自身反应性B细胞驱动.
布鲁顿氨酸激酶 (BTK) 是B细胞发育和功能的关键调节剂,使其成为SLE的治疗点.
BTK 抑制剂通过调节 B 细胞活性而不会导致枯竭,为生物药物提供了有希望的替代品.

研究的目的:

详细阐述BTK在SLE发病过程中的关键作用.
审查BTK抑制剂在SLE治疗中的临床进展.
讨论当前BTK抑制剂所面临的挑战和局限性.

主要方法:

从易患狼的小鼠模型中对临床前数据的审查.
对SLE患者BTK抑制剂的临床试验数据的分析.
讨论药物的疗效,安全性概况和选择性.

主要成果:

临床前研究表明,BTK抑制在狼模型中的治疗潜力很有希望.
临床试验表明,目前的BTK抑制剂 (例如,elsubrutinib,evobrutinib) 面临着有效性和安全性的挑战.
需要改进的BTK抑制剂,增强强效和选择性.

结论:

在SLE的发病过程中,BTK扮演着重要的角色,使其抑制成为一种可行的治疗策略.
目前的BTK抑制剂在临床有效性和安全性方面存在局限性,需要进一步开发.
本综述为设计下一代BTK抑制剂提供了洞察力,以更有效地治疗SLE.

关键词:

B 细胞 B 细胞 B 细胞布鲁顿的铁氨基激酶.一种共价性结合.小分子抑制剂小分子抑制剂系统性红血性狼 (Systemic lupus erythematosusus) 是一种全身性狼.

更多相关视频

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

相关概念视频

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...